Masimo CORP 10-K annual reports

Masimo Corporation filed an amendment to its 2025 Annual Report to provide required disclosures regarding directors, executive compensation, and corporate governance.

Masimo Corporation's 2025 annual report highlights robust healthcare revenue growth, the planned sale of its non-healthcare business, and a definitive merger agreement with Danaher Corporation.

Masimo Corporation navigates leadership changes and strategic realignments while reporting a slight revenue increase but a significant net loss for fiscal year 2024, driven by impairment charges and legal expenses.

Masimo Corporation has filed an amendment to its 2023 annual report to include previously omitted information regarding directors, executive compensation, and other corporate governance matters.

Masimo Corporation updates its severance protection plan for a key executive and files its annual report, detailing financial results and strategic initiatives amidst a challenging economic landscape.